Channels - Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer :: FRELIP Discovery

Similar Items: Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

Quick Look
Oncolytic virotherapy in upper gastrointestinal tract cancers
Quick Look
Editorial announcing PubMed indexing of Oncolytic Virotherapy
Quick Look
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
Quick Look
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
Quick Look
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Quick Look
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Quick Look
Three-dimensional tumor cell cultures employed in virotherapy research
Quick Look
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
Quick Look
Potential of oncolytic viruses in the treatment of multiple myeloma
Quick Look
Development and applications of oncolytic Maraba virus vaccines
Quick Look
A cautionary note on the selectivity of oncolytic poxviruses
Quick Look
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
Quick Look
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
Quick Look
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Quick Look
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Quick Look
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Quick Look
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Quick Look
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Quick Look
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Quick Look
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer
Quick Look
Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study
Quick Look
Integrative Transcriptomic Signature of tRNA‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis
Quick Look
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
Quick Look
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non‐Squamous Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study